Objectives. To establish the cut-off values for inactive disease, as well as low disease activity
(LDA), moderate disease activity (MDA) and high disease activity (HDA) in non-systemic JIA …

Background Pain is a frequent and inevitable factor affecting the quality of life among older
people. Several studies have highlighted the ineffectiveness of treating chronic pain among …

Objective. To describe the occurrence and main clinical and laboratory findings of patients
having both juvenile idiopathic arthritis (JIA) and diabetes mellitus type 1 (DM-1) in a period …

Background In a chronic pain-causing disease such as juvenile idiopathic arthritis, the
quality of coping with pain is crucial. Parents have a substantial influence on their children's …

Background Etanercept (ETN) is widely used tumour necrosis factor (TNF) blocker in the
treatment of juvenile idiopathic arthritis (JIA) when traditional synthetic disease modifying …

Abstract Objective The Pain Coping Questionnaire (PCQ), the first validated pain coping
measurement developed specifically for children, has lacked proper validation in Finnish …

Objectives To validate cut-offs of the Juvenile Arthritis Disease Activity Score 10 (JADAS10)
and clinical JADAS10 (cJADAS10) and to compare them with other patient cohorts. Methods …

Aim: To evaluate the occurrence of autoimmune diseases in first‐degree relatives of children
with juvenile idiopathic arthritis (JIA) and to compare the figures with published population …

Background and aims Pain is an evident factor affecting the quality of life in all age groups.
The objective was to examine the prevalence of self-reported SF-36 bodily pain and pain …

Cryopyrin‐associated periodic syndrome (CAPS) is caused by a mutation in the NLRP 3
gene encoding cryopyrin production. Overproduction of interleukin‐1 (IL‐1) leads to …